Idecabtagene Vicleucel
bms
['car t']
 dr. doris hansen chats with us about ide-cel, a bcma-directed car t-cell therapy, was approved by the fda in 3 of 2 0 2 1 in rrmm #asco22 #oncotwitter 
Produce, Find, and Distribute the latest and highest quality  multimedia to oncologists, hematologists and researchers.